Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. November 2025 08:20 ET | Quelle: Research and Markets

Her3-Targeted Immunotherapies Pipeline and Competitive Intelligence Report

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of Her3-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
25. November 2025 08:00 ET | Quelle: Immuneering Corporation

Immuneering to Present at the Piper Sandler 37th Annual Healthcare Conference

Immuneering to Present at the Piper Sandler 37th Annual Healthcare Conference
14. November 2025 07:00 ET | Quelle: Castle Biosciences, Inc.

New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity

Castle will present new data showing the clinical value of DecisionDx-Melanoma in improving sentinel lymph node biopsy decision making at Dermato-Onco2025.
24. Oktober 2025 04:05 ET | Quelle: Castle Biosciences, Inc.

New Analysis of 13,560 Patients Demonstrates DecisionDx®-Melanoma Stratifies Risk Across Histological Subtypes; Findings to be Presented at Fall Clinical Dermatology Conference

Castle is presenting data on DecisionDx®-Melanoma and its pipeline atopic dermatitis (AD) test at the 25th Annual Fall Clinical Dermatology Conference.
14. Oktober 2025 13:00 ET | Quelle: DelveInsight Business Research LLP

Melanoma Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

New York, USA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Melanoma Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight The melanoma market...
08. Oktober 2025 05:12 ET | Quelle: Research and Markets

Cutaneous Squamous Cell Carcinoma Market Forecast Report 2025-2035, with Focus on Regeneron Pharmaceuticals, Sanofi, Merck & Co., Checkpoint Therapeutics, Incyte, and Sirnaomics

Dublin, Oct. 08, 2025 (GLOBE NEWSWIRE) -- The "Cutaneous Squamous Cell Carcinoma Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has...
25. September 2025 00:08 ET | Quelle: Immuneering Corporation

Immuneering Announces Pricing of $175 Million Underwritten Public Offering of Class A Common Stock and Concurrent $25 Million Private Placement of Class A Common Stock to Sanofi

Immuneering Announces Pricing of $175 Million Underwritten Public Offering of Class A Common Stock and Concurrent $25 Million Private Placement of Class A
24. September 2025 16:05 ET | Quelle: Immuneering Corporation

Immuneering Announces Proposed Underwritten Public Offering of Class A Common Stock and Pre-Funded Warrants and Proposed Concurrent Private Placement of Class A Common Stock and Class B Common Stock to Sanofi

Immuneering Announces Proposed Underwritten Public Offering of Class A Common Stock and Pre-Funded Warrants and Proposed Concurrent Placement to Sanofi
24. September 2025 16:01 ET | Quelle: Immuneering Corporation

Immuneering Announces Extraordinary 86% Overall Survival at 9 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP

Immuneering Announces Extraordinary 86% Overall Survival at 9 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP
22. September 2025 09:35 ET | Quelle: Research and Markets

BRAF Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast 2015-2036

Dublin, Sept. 22, 2025 (GLOBE NEWSWIRE) -- The "BRAF Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036" report has been added to ResearchAndMarkets.com's...

Nächste Seite